# IBBIS

launched May 2024 as a free, open-source synthesis-screening package more robust against evasion attempts — including AI-generated sequences — than basic sequence-matching approaches, spun out of a US biosecurity nonprofit into an independent Swiss foundation.


Source: https://cn.bioecon.ru/companies/ibbis/
Updated: 2026-08-15

- 国家: Switzerland

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 隶属机构 | 由核威胁倡议组织（NTI）\| bio孵化 | https://ibbis.bio/about/, https://www.longtermwiki.com/wiki/E536 |
| 研究方向 | DNA合成筛查、生物安全规范及降低新兴生物风险 | https://ibbis.bio/about/, https://www.longtermwiki.com/wiki/E536 |
| 总部 | 瑞士日内瓦 | https://ibbis.bio/about/, https://www.longtermwiki.com/wiki/E536 |
| 科研资助 | Founders Pledge提供的$300万启动资助 | https://www.longtermwiki.com/wiki/E536 |
| 主要研究人员 | Piers Millett（执行主任）、Tessa Alexanian（技术负责人）、Rassin Lababidi（技术负责人）、Sophie Peresson（技术负责人） | https://www.longtermwiki.com/wiki/E536 |
| 论文产出 | Common Mechanism（commec）软件包，以及多份关于生物安全筛查的技术白皮书与文章 | https://ibbis.bio/our-work/common-mechanism/, https://ibbis.bio/our-work/common-mechanism/faq/, https://ibbis.bio/our-work/common-mechanism/get-started/ |

独立来源: longtermwiki.com

## 技术

- [DNA合成生物安全筛查](https://cn.bioecon.ru/technology/dna-synthesis-biosecurity-screening/)